- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-1 Inhibitor
Total 106478 results
-
Merck Sharp & Dohme LLCActive, not recruitingFallopian Tube Neoplasms | Carcinoma, Ovarian Epithelial | Ovarian CancerUnited States, Germany, Israel, Canada, China, Australia, Belgium, Brazil, Chile, Colombia, Denmark, Finland, France, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Poland, Russian Federation, Turkey and more
-
Merck Sharp & Dohme LLCActive, not recruitingNon-Small Cell Lung CancerPoland, United States, Argentina, Australia, Austria, Brazil, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Norway, Romania, Russian Federation, Spain, Switzerland, Taiwan, Turkey, Ukr... and more
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCGynecologic Oncology Group; European Network for Gynaecological Oncological...Active, not recruitingEndometrial NeoplasmsUnited States, Argentina, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Norway, Poland, Russian Federation, Spain, Sweden, Taiwan, T... and more
-
Merck Sharp & Dohme LLCCompletedUrothelial Carcinoma Associated 1 RNA, Human
-
Merck Sharp & Dohme LLCNovartis PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more
-
University Hospital, BordeauxRecruitingMetastatic Renal Cell Carcinoma | Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC ScoreFrance
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, HepatocellularKorea, Republic of, China, Hong Kong, Malaysia, Taiwan
-
Yongchang ZhangRecruitingHER2 Insertion Mutation Positive Advanced NSCLCChina
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCRecruitingSmall Cell Lung CancerUnited States, Australia, Belgium, Bulgaria, Canada, China, France, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Portugal, Romania, Russian Federation, Serbia, South Africa, Spain, Turkey, Ukraine, United... and more
-
Tianjin Medical University Cancer Institute and...RecruitingEarly Stage Non-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCEisai Inc.RecruitingSquamous Cell Carcinoma of Head and NeckUnited States, Australia, Canada, Denmark, France, Israel, Korea, Republic of, Norway, Portugal, Romania, Spain, Taiwan, United Kingdom, Colombia, Brazil
-
Merck Sharp & Dohme LLCGynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerPoland, Korea, Republic of, United States, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine
-
Merck Sharp & Dohme LLCActive, not recruitingColorectal CancerUnited States, Poland, Belgium, Canada, Colombia, Costa Rica, Denmark, Estonia, France, Germany, Greece, Guatemala, Hungary, Italy, Korea, Republic of, Lithuania, Netherlands, Romania, Russian Federation, Spain, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerChina
-
Merck Sharp & Dohme LLCActive, not recruitingGastric Cancer | Gastroesophageal Junction CancerUnited States, Belgium, Brazil, Canada, Chile, China, Estonia, France, Germany, Guatemala, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Philippines, Poland, Russian Federation, Singapore, Taiwan, Ukraine, United...
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Non-Small Cell Lung CancerPoland, Russian Federation, United States, Australia, Canada, Hong Kong, Ireland, Italy, Japan, Korea, Republic of, Singapore, South Africa, Spain, Switzerland, Taiwan, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom, Bulgaria, Czechia, Hu... and more
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedMetastatic Triple Negative Breast Cancer
-
University Hospital HeidelbergDepartment of Dermatology, Heidelberg University HospitalCompletedMelanoma | Exercise | PD-1 AntibodiesGermany
-
Genentech, Inc.Completed
-
NYU Langone HealthMerck Sharp & Dohme LLCTerminatedSmall Cell Lung Cancer (SCLC)United States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Chile, China, France, Germany, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.CompletedNon-small Cell Lung CancerChina, Israel, United States, Australia, Canada, Colombia, Estonia, France, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Taiwan, Turkey, Ukraine
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
Merck Sharp & Dohme LLCEisai Inc.CompletedAdvanced MelanomaCanada, United States, Australia, Spain, Sweden
-
National Cancer Institute (NCI)Not yet recruitingMetastatic Melanoma | Locally Advanced Melanoma | Metastatic Alveolar Soft Part Sarcoma | Metastatic Non Small Cell Lung Cancer | Metastatic Hepatocellular Carcinoma | Locally Advanced Hepatocellular Carcinoma | Metastatic Small Cell Lung Cancer | Locally Advanced Non Small Cell Lung Cancer | Locally... and other conditionsUnited States
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Head and Neck Neoplasms | Colorectal NeoplasmsAustralia, Hong Kong
-
Xuhua DuanRecruiting
-
Ascletis Pharmaceuticals Co., Ltd.RecruitingHIV Infections | HIV-1-infection | PD-L1 Gene MutationChina
-
Diwakar DavarMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell CarcinomaUnited States
-
The Affiliated Hospital of Qingdao UniversityUnknown
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingHepatocellular CarcinomaChina
-
Hunan Cancer HospitalCompleted
-
Jiangsu vcare pharmaceutical technology co., LTDCompletedHealthy Subjects | PK/PDChina
-
RenJi HospitalRecruitingUrothelial Carcinoma Bladder | PD-1 InhibitorChina
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCRecruitingEsophageal Squamous Cell CarcinomaJapan, Korea, Republic of, Taiwan, China, Norway, Italy, Switzerland, Brazil, Germany, Singapore, Turkey, Thailand, Chile
-
Merck Sharp & Dohme LLCActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC)Japan, Italy, Brazil, Chile, France, Germany, Korea, Republic of, Norway, Singapore, Switzerland, Taiwan, Thailand, Turkey
-
Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Brazil, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, United Kingdom
-
Mahmoud Ramadan mohamed ElkazzazNot yet recruiting
-
Waterstone Hanxbio Pty LtdCompletedAdvanced Solid TumorAustralia
-
Ono Pharmaceutical Co. LtdSuspendedPlaque PsoriasisUnited Kingdom, Moldova, Republic of, Romania